Franca Fruzzetti
Department of Obstetrics & Gynecology
Santa Chiara Hospital
via Roma 35
56100 Pisa
Italy
Name/email consistency: high
- Beyaz®: an oral contraceptive fortified with folate. Fruzzetti, F. Womens. Health. (Lond. Engl) (2012)
- Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome. Fruzzetti, F., Perini, D., Lazzarini, V., Parrini, D., Gambacciani, M., Genazzani, A.R. Fertil. Steril. (2010)
- Review of clinical experience with estradiol in combined oral contraceptives. Fruzzetti, F., Bitzer, J. Contraception (2010)
- Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels. Fruzzetti, F., Perini, D., Lazzarini, V., Parrini, D., Genazzani, A.R. Fertil. Steril. (2009)
- Hyperandrogenemia influences the prevalence of the metabolic syndrome abnormalities in adolescents with the polycystic ovary syndrome. Fruzzetti, F., Perini, D., Lazzarini, V., Parrini, D., Genazzani, A.R. Gynecol. Endocrinol. (2009)
- Attitudes of Italian women concerning suppression of menstruation with oral contraceptives. Fruzzetti, F., Paoletti, A.M., Lombardo, M., Carmignani, A., Genazzani, A.R. Eur. J. Contracept. Reprod. Health. Care (2008)
- The oral contraceptive containing 30 microg of ethinylestradiol plus 3 mg of drospirenone is able to antagonize the increase of extracellular water occurring in healthy young women during the luteal phase of the menstrual cycle: an observational study. Fruzzetti, F., Lello, S., Lazzarini, V., Fratta, S., Orrù, M., Sorge, R., Minerba, L., Ricci, C., Genazzani, A.R., Melis, G.B., Paoletti, A.M. Contraception (2007)
- Effect of an oral contraceptive containing 30 microg ethinylestradiol plus 3 mg drospirenone on body composition of young women affected by premenstrual syndrome with symptoms of water retention. Fruzzetti, F., Lazzarini, V., Ricci, C., Quirici, B., Gambacciani, M., Paoletti, A.M., Genazzani, A.R. Contraception (2007)
- Effect of long-term naltrexone treatment on endocrine profile, clinical features, and insulin sensitivity in obese women with polycystic ovary syndrome. Fruzzetti, F., Bersi, C., Parrini, D., Ricci, C., Genazzani, A.R. Fertil. Steril. (2002)
- A 12-month clinical investigation with a 24-day regimen containing 15 microg ethinylestradiol plus 60 microg gestodene with respect to hemostasis and cycle control. Fruzzetti, F., Genazzani, A.R., Ricci, C., De Negri, F., Bersi, C., Carmassi, F. Contraception (2001)
